Similar articles for PMID: 15664246

Year	Number of Results
1950	1
1996	1
2000	1
2001	1
2002	1
2003	5
2004	8
2005	14
2006	6
2007	9
2008	11
2009	4
2010	8
2011	7
2012	9
2013	7
2014	4
2015	5
2016	3
2017	5
2018	2
2019	2
2020	1
2021	4
2022	3
2023	1
2024	0

1

Apoptosis on hepatoma cells but not on primary hepatocytes by histone deacetylase inhibitors valproate and ITF2357.

Armeanu S, Pathil A, Venturelli S, Mascagni P, Weiss TS, Göttlicher M, Gregor M, Lauer UM, Bitzer M. Armeanu S, et al. J Hepatol. 2005 Feb;42(2):210-7. doi: 10.1016/j.jhep.2004.10.020. J Hepatol. 2005. PMID: 15664246

2

HDAC inhibitor treatment of hepatoma cells induces both TRAIL-independent apoptosis and restoration of sensitivity to TRAIL.

Pathil A, Armeanu S, Venturelli S, Mascagni P, Weiss TS, Gregor M, Lauer UM, Bitzer M. Pathil A, et al. Hepatology. 2006 Mar;43(3):425-34. doi: 10.1002/hep.21054. Hepatology. 2006. PMID: 16583461

3

Modulation of pro- and anti-apoptotic factors in human melanoma cells exposed to histone deacetylase inhibitors.

Facchetti F, Previdi S, Ballarini M, Minucci S, Perego P, La Porta CA. Facchetti F, et al. Apoptosis. 2004 Sep;9(5):573-82. doi: 10.1023/B:APPT.0000038036.31271.50. Apoptosis. 2004. PMID: 15314285 Free article.

4

Epigenetic combination therapy as a tumor-selective treatment approach for hepatocellular carcinoma.

Venturelli S, Armeanu S, Pathil A, Hsieh CJ, Weiss TS, Vonthein R, Wehrmann M, Gregor M, Lauer UM, Bitzer M. Venturelli S, et al. Cancer. 2007 May 15;109(10):2132-41. doi: 10.1002/cncr.22652. Cancer. 2007. PMID: 17407132 Free article.

5

The histone deacetylase inhibitors suberoylanilide hydroxamic (Vorinostat) and valproic acid induce irreversible and MDR1-independent resistance in human colon cancer cells.

Fedier A, Dedes KJ, Imesch P, Von Bueren AO, Fink D. Fedier A, et al. Int J Oncol. 2007 Sep;31(3):633-41. Int J Oncol. 2007. PMID: 17671692

6

SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib.

Emanuele S, Lauricella M, Carlisi D, Vassallo B, D'Anneo A, Di Fazio P, Vento R, Tesoriere G. Emanuele S, et al. Apoptosis. 2007 Jul;12(7):1327-38. doi: 10.1007/s10495-007-0063-y. Apoptosis. 2007. PMID: 17351739

7

SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.

Lai JP, Yu C, Moser CD, Aderca I, Han T, Garvey TD, Murphy LM, Garrity-Park MM, Shridhar V, Adjei AA, Roberts LR. Lai JP, et al. Gastroenterology. 2006 Jun;130(7):2130-44. doi: 10.1053/j.gastro.2006.02.056. Gastroenterology. 2006. PMID: 16762634

8

Histone deacetylase inhibitor suberoylanilide hydroxamic acid suppresses the pro-oncogenic effects induced by hepatitis B virus pre-S2 mutant oncoprotein and represents a potential chemopreventive agent in high-risk chronic HBV patients.

Hsieh YH, Su IJ, Yen CJ, Tsai TF, Tsai HW, Tsai HN, Huang YJ, Chen YY, Ai YL, Kao LY, Hsieh WC, Wu HC, Huang W. Hsieh YH, et al. Carcinogenesis. 2013 Feb;34(2):475-85. doi: 10.1093/carcin/bgs365. Epub 2012 Nov 21. Carcinogenesis. 2013. PMID: 23172669

9

Histone deacetylase inhibitors synergistically potentiate death receptor 4-mediated apoptotic cell death of human T-cell acute lymphoblastic leukemia cells.

Sung ES, Kim A, Park JS, Chung J, Kwon MH, Kim YS. Sung ES, et al. Apoptosis. 2010 Oct;15(10):1256-69. doi: 10.1007/s10495-010-0521-9. Apoptosis. 2010. PMID: 20582477

10

[ITF-2357 on inhibition myeloid leukemic cell lines cells proliferation in vitro and its mechanism].

Yu WJ, Wang L, You LS, Mei C, Ma QL, Jin J. Yu WJ, et al. Zhonghua Xue Ye Xue Za Zhi. 2012 May;33(5):366-70. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 22781793 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

113 results

Results by year